J.T.The DD King's Real-Time Scans

[4weed]

More-USMJ-DD-From-CEO-LTR-Released-Today ...

Full Release: http://finance.yahoo.com/news/north-american-cannabis-holdings-plans-213000102.html

The trading volume going from $20,000 a day to $100,000 a day over the past two months is an indication that the market has taken notice of USMJ. Two months however, is not an adequate period for the market to determine the value of USMJ’s long-term plan.

Once the market learns more about the recent CityBlends acquisition; the demographic value of the first AmeriCanna Café site selection; the patent pending healthcare technology; the test results from early cannabis treatment trials and the resilience of USMJ’s spin-off capitalization model, then the pps will be able to find traction.

By delivering the results to come from the continued execution of the USMJ business plan, room for speculation on the Company’s value will be reduced. Message board emotional appeals will carry less weight in the face of actual results.

Last year, nobody knew who we were and we still continued to execute on our business plan. Now, people know who we are and some have bought into our plan while others are clearly betting against us in a hope to enjoy a large profit on a decreased pps. We are grateful for the market attention and just like last year when nobody knew or cared who we were, we will continue to execute on our business plan.

USMJ is one of more than 50 companies included in the Marijuana Index for OTC Current Information Companies:

MARIJUANA INDEX

USMJ is one of the top-ten most actively traded stocks included in the Index. USMJ is also in the bottom-ten with one of the lowest market capitalization values. No other company in the bottom-ten market capitalization values is also in the top-ten most actively traded.

Again, the increased trading volume indicates that USMJ has the market’s attention. On the other hand, the market capitalization value is an indication that the market has yet to learn about the underlying value of USMJ.

I reiterate my contention that the best prescription for the Company’s long-term pps is for the Company to continue executing on its business plan.